The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling
- Resource Type
- Article
- Authors
- Laplantine, Emmanuel; Chable-Bessia, Christine; Oudin, Anne; Swain, Jitendryia; Soria, Adèle; Merida, Peggy; Gourdelier, Manon; Mestiri, Sarra; Besseghe, Indira; Bremaud, Erwan; Neyret, Aymeric; Lyonnais, Sebastien; Favard, Cyril; Benaroch, Philippe; Hubert, Mathieu; Schwartz, Olivier; Guerin, Maryse; Danckaert, Anne; Del Nery, Elaine; Muriaux, Delphine; Weil, Robert
- Source
- In iScience 21 October 2022 25(10)
- Subject
- Language
- ISSN
- 2589-0042